Category: Latest News
-
Victory Marine Holdings Reduces Convertible Debt by More Than 95% as Commercial Expansion Accelerates (USOTC:VMHG)
Victory Marine Holdings reported a significant reduction in convertible debt alongside continued commercialization of its beverage and wellness platform, marking the first full quarter of execution following its March 2026 reverse merger. Key Investor Takeaways Why VMHG Stock Is in Focus Victory Marine Holdings (USOTC:VMHG), through its operating subsidiary Dunn & Groux Beverage Holdings, highlighted…
-
Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital
Cardiff Oncology has secured a $10 million registered direct offering, providing additional capital for working capital and general corporate purposes as the company continues advancing its lead oncology program. Key Investor Takeaways Why CRDF Stock Is in Focus Cardiff Oncology (NASDAQ:CRDF) announced definitive agreements for a registered direct offering expected to generate approximately $10 million…
-
Rekor Systems Reports Preliminary Q2 Financial Improvement as Cost Cuts Drive Toward Adjusted EBITDA Profitability
Rekor Systems’ preliminary second-quarter results point to stronger operating performance following a broad restructuring effort, while management now expects to reach Adjusted EBITDA profitability during the second half of 2026. Key Investor Takeaways Why REKR Stock Is in Focus Rekor Systems (NASDAQ:REKR) reported preliminary, unaudited second-quarter 2026 financial results that suggest meaningful progress in its…
-
VivoSim Receives $5 Million Milestone Payment From Eli Lilly and Forecasts 500%+ FY2027 Revenue Growth
The milestone payment strengthens VivoSim’s cash position while management projects significant revenue growth driven by expanding demand for its human-based preclinical testing platform. Key Investor Takeaways Why VIVS Stock Is In Focus The key catalyst is VivoSim’s announcement that it has received a $5 million milestone payment from Eli Lilly related to an inflammatory bowel…
-
IMAX partners with Goer Dynamics to develop in-vehicle entertainment platform (IMAX)
IMAX (NYSE:IMAX) and Goer Dynamics have announced a strategic partnership to develop an IMAX-branded in-vehicle entertainment system, with commercial production scheduled to begin before the end of 2026. New platform targets premium automotive market The jointly developed system will combine Goer Dynamics’ automotive technology with IMAX’s entertainment expertise to deliver an immersive viewing experience inside…
-
Progressive tops second-quarter earnings forecasts, but shares slide on margin concerns (PGR)
Progressive Corp. (NYSE:PGR) reported stronger-than-expected second-quarter earnings, supported by continued premium growth and higher investment gains. Despite the solid results, the insurer’s shares fell around 4% in premarket trading as investors focused on weaker underwriting margins. Earnings beat driven by premium growth The company posted second-quarter earnings of 5.67 dollars per share, comfortably ahead of…
-
Nebius shares rise after unveiling partner-led AI cloud expansion strategy (NBIS)
Nebius (NASDAQ:NBIS) shares gained 2.75% on Wednesday after the AI cloud infrastructure company introduced a new partnership model designed to expand its cloud platform through third-party data centre operators while limiting its own capital investment. New model shifts infrastructure costs to partners Under the programme, infrastructure partners will finance, own and operate the data centres…
-
GameStop expands on-demand delivery through Uber Eats partnership (GME)
GameStop (NYSE:GME) has partnered with Uber Technologies (NYSE:UBER) to make its products available through the Uber Eats platform, giving customers across the United States access to on-demand and scheduled delivery of gaming products. Gaming products available through Uber Eats Under the new agreement, customers can order a wide range of GameStop merchandise, including video games,…
-
Ernexa Therapeutics shares soar 30% after independent study validates cancer therapy (ERNA)
Ernexa Therapeutics (NASDAQ:ERNA) shares surged 30% on Wednesday after the company announced positive independent preclinical data supporting its lead cell therapy candidate, ERNA-101, for the treatment of ovarian cancer. Independent research confirms earlier findings The company said an independent contract research organisation successfully replicated previous results, demonstrating complete tumour clearance and extended survival in a…
-
Conagra Brands shares fall after weak fiscal 2027 guidance disappoints investors (CAG)
Conagra Brands (NYSE:CAG) shares fell 3.2% in premarket trading after the packaged food company issued a weaker-than-expected earnings outlook for fiscal 2027, overshadowing fourth-quarter results that narrowly exceeded Wall Street forecasts. Fourth-quarter results edge past expectations For the quarter ended 31 May 2026, Conagra reported adjusted earnings per share of 0.47 dollars, slightly above analysts’…